baber/WOPTO huggingface dataset:
Patent NZ-241970-A (NZ)
Title: Ethanol production by recombinant host
Inventor: INGRAM LONNIE O
IPC: C12N15/52
Filed: 1992-03-16
Abstract: Novel plasmids comprising genes which code for the alcohol dehydrogenase and pyruvate decarboxylase are described. Also described are recombinant hosts which have been transformed with genes coding for alcohol dehydrogenase and pyruvate. By virtue of their transformation with these genes, the recombinant hosts are capable of producing significant amounts of ethanol as a fermentation product. Also disclosed are methods for increasing the growth of recombinant hosts and methods for reducing the accumulation of undesirable metabolic products in the growth medium of these hosts. Also disclosed are recombinant host capable of producing significant amounts of ethanol as a fermentation product of oligosaccharides and plasmids comprising genes encoding polysaccharases, in addition to the genes described above which code for the alcohol dehydrogenase and pyruvate decarboxylase. Further, methods are described for producing ethanol from oligomeric feedstock using the recombinant hosts described above. Also provided is a method for enhancing the production of functional proteins in a recombinant host comprising overexpressing an adhB gene in the host. Further provided are process designs for fermenting oligosaccharide-containing biomass to ethanol.
Patent NZ-245974-A (NZ)
Title: Heterocyclic ketone derivatives, preparation, intermediates and pharmaceutical compositions thereof
Inventor: GOTO GIICHI
IPC: C07D405/12
Filed: 1993-02-23
Abstract: A compound of the formula: <CHEM> wherein R<1> is H or an optionally substituted hydrocarbon or acyl group; ring A is an optionally further substituted benzene ring; n is an integer of 1 to 10; R<2>, R<3> and R<4> are H or an optionally substituted hydrocarbon group; R<3> and R<4> may form an optionally substituted heterocyclic group, taken together with the adjacent nitrogen atom; k is an integer of 0 to 3; and m is an integer of 1 to 8; provided that when k=0 and m=2, n is an integer of not less than 2 or a pharmaceutically acceptable salt thereof, exhibiting excellent cholinesterase inhibitory activity and monoamine reuptake inhibitory activity, thus being useful as therapeutic/prophylactic medicaments of senile dementia.
Patent NZ-247122-A (NZ)
Title: Tetrazole-quinazolin-4-one derivatives and medicaments
Inventor: PEGG STEPHEN JOHN
IPC: A61K31/517
Filed: 1993-03-11
Abstract: The invention relates to quinazoline derivatives, or pharmaceutically-acceptable salts thereof, which possess anti-tumour activity; to processes for their manufacture; and to pharmaceutical compositions containing them. The invention provides a quinazoline of the formula:- <CHEM>  wherein R<1> is (1-4C)alkyl; the quinazoline ring may optionally bear one or two further substituents selected from halogeno, (1-4C)alkyl and (1-4C)alkoxy;  R<2> is hydrogen or (1-4C)alkyl;  R<3> includes hydrogen and (1-4C)alkyl; and  Ar is optionally substituted phenylene or heterocyclene; or a pharmaceutically-acceptable salt or ester thereof.
Patent NZ-248069-A (NZ)
Title: Topical liquid composition for skin application comprising retinoic acid or an ester for treating dermatological disorders, together with alpha tocopherol to reduce skin irritation
Inventor: FIEDLER NAGY CHRISTA
IPC: A61K8/00
Filed: 1993-07-05
Abstract: Compositions of retinoic acids and tocopherols may be applied topically without producing retinoic acid-induced skin irritation.
Patent NZ-250817-A (NZ)
Title: Polymer comprising hydrophilic monomer units and units of a branched hydroxyalkyl(meth)acrylate or -(meth)acrylamide; ophthalmic lenses
Inventor: VANDERLAAN DOUGLAS G
IPC: B29D11/00
Filed: 1994-02-03
Abstract: A polymer composition composed of the reaction product of a hydrophilic monomer and an acyclic monomer is disclosed. The preferred hydrophilic monomer is hydroxyethyl methacrylamido (HMA), and the preferred acyclic monomer is hydroxyoctyl methacrylate (HOMA). The monomeric components can be polymerized in a polystyrene mold to make contact lenses, and when swollen with water, are suitable for use as soft hydrogel contact lenses.The preferred compositions also include a zwitterionic monomer, such as a sulfobetaine, and a crosslinking agent, such as ethyleneglycol dimethacrylate (EGDMA).Hydrogel contact lenses made from these polymers exhibit high water content and mechanical strength, and are compatible with polystyrene molds.
Patent NZ-258251-A (NZ)
Title: Absorbent structure manufacture - flash-dried cellulose fibres dry-formed to 50-1500 g/m2 and compressed
Inventor: WIDLUND URBAN
IPC: A61F13/20
Filed: 1993-11-15
Abstract: PCT No. PCT/SE93/00973 Sec. 371 Date Aug. 2, 1995 Sec. 102(e) Date Aug. 2, 1995 PCT Filed Nov. 15, 1993 PCT Pub. No. WO94/10955 PCT Pub. Date May 26, 1994A method for the manufacturing of an absorbent structure in an absorbent article, such as a sanitary napkin, tampon, panty protector, wound or sore dressing and like articles is produced by using absorbent material in roll form directly in the product without first defibrating the material and then forming a mat. The material possesses good dispersion properties and swelling properties, which are meaningful to the function of the product. A high surface dryness is obtained, among other things. In addition to cellulose fibers, the absorbent structure may also include superabsorbent material and/or binding fibers, among other ingredients. The pulp mat is very thin, therewith obviating the need to compress the mat further in the product. In the case of certain product applications, the material is softened mechanically prior to its use as an absorbent material.
Patent NZ-275678-A (NZ)
Title: Use of 5-alpha-reductase 2 inhibitors to prepare medicaments to treat androgenic alopecia
Inventor: GORMLEY GLENN J
IPC: A61K31/565
Filed: 1994-10-11
Abstract: The instant invention involves a method of treating and/or reversing androgenic alopecia and promoting hair growth, and methods of treating acne vulgaris, seborrhea, and female hirsutism, by administering to a patient in need of such treatment a 5 alpha -reductase 2 inhibitor such as finasteride, in a dosage amount under 5 mgs/day.
Patent NZ-290255-A (NZ)
Title: Phased array spread spectrum receiving system
Inventor: SCHILLING DONALD L
IPC: H04B1/707
Filed: 1995-06-16
Abstract: A phased array spread spectrum system for maximizing signal strength of a spread-spectrum signal with multipath through the use of a first RF/IF section 21, a second RF/IF section 22, a first digital delay device 27, a second digital delay device 28, a first summer 29, a second summer 30, a despreader 31, a magnitude device 32, a shift register 33, and a comparator 34. The first RF/IF section 21 receives a plurality of spread-spectrum signals and the second RF/IF section 22 receives a plurality of phased versions of the plurality of spread-spectrum signals. The first and second digital delay devices 27, 28 delay the received plurality of spread-spectrum signals with respect to the plurality of phased versions of the plurality of spread-spectrum signals by a plurality of delays. The first and second summers 29, 30 combine the delayed spread-spectrum signals and the plurality of phased versions of the plurality of spread-spectrum signals as a plurality of combined signals. The despreader 31 despreads the plurality of combined signals as a plurality of despread signals. The magnitude device 32 generates a plurality of magnitude values from the plurality of despread signals. The shift register 33 stores a plurality of previous-magnitude values previously generated by the magnitude device 32 and a plurality of present magnitude values presently generated by the magnitude device 32. The comparator 34 compares the previous-magnitude values and the present-magnitude values and, responsive to the comparison, outputs a plurality of comparison signals. The first and second digital delay devices 27, 28 respond to the plurality of comparison signals by lengthening or shortening the plurality of delays.
Patent NZ-294889-A (NZ)
Title: Halogenated esters useful as intermediates for pesticides
Inventor: BOWDEN MARTIN CHARLES
IPC: B01J31/02
Filed: 1995-11-02
Abstract: The invention provides novel compounds of formula:CF3-CXCl-CH(OH)CH2-C(CH3)2-CH2-CO2R(I)where X represents chloro or bromo and R represents hydrogen or alkyl of up to 4 carbon atoms, processes for preparing them and their use as intermediates in the preparation of insecticidal cyclopropane derivatives. Also provided are novel compounds of formula:BrCH2-CH2-C(CH3)2-CH2-CO2R(IV)wherein R represents alkyl of up to 4 carbon atoms, useful as intermediates in the preparation of the compounds of formula I.
Patent NZ-309649-A (NZ)
Title: Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
Inventor: YESAIR DAVID W
IPC: A61K9/107
Filed: 1996-06-06
Abstract: A composition of mixed lipid colloidal particles is disclosed containing nonesterified fatty acids having 8-24 carbon atoms of saturated, unsaturated and polyunsaturated fatty acid, monoglycerides which are monoesters of glycerol and fatty acids having 8-24 carbon atoms of saturated, unsaturated and polyunsaturated fatty acid, lysophosphatidylcholine in which the fatty acid moiety has 8-24 carbon atoms of saturated, unsaturated and polyunsaturated fatty acid and a titrating agent. The compositions can optionally also contain bile salts and/or other biologically compatible surfactants. These compositions form submicron size colloidal particles and can act as vehicles for transporting orally administered drugs, sources of calories in the form of readily absorbable and sustained absorption of fats, sources of readily absorbable polyunsaturated fat and/or choline, and as particles for topical application to the skin. Methods of making these particles are also described. Also disclosed are the use of the compositions in the manufacture of medicaments and the use of the compositions for the delivery of choline (and fats).
Patent NZ-320343-A (NZ)
Title: Water-redispersible powdered film-forming polymer composition characterised by inclusion of styrene/butadiene to lessen agglomeration of powdered mix
Inventor: GUERIN GILLES
IPC: C09D201/00
Filed: 1996-10-21
Abstract: A powdered pulverulent composition that is completely or almost completely redispersible in water, based on a film-forming polymer prepared from ethylenically unsaturated monomers. The powdered pulverulent composition is used as an adjuvant in inorganic hydraulic binding compositions to improve the properties after hardening, such as adhesion to various substrates, leaktightness, flexibility and mechanical properties. The redispersible powder is stable on storage without agglomeration. The powder is prepared with at least one ethylenically unsaturated monomer, at least one non-ionic surfactant chosen from polyoxyalkylated derivatives and at least one water soluble compound chosen from polyelectrolytes from the family of weak acids.
Patent NZ-330416-A (NZ)
Title: Uht sterilized or refridgerated lactic cream containing starch, maltodextrin and xanthan
Inventor: MERZ MADELEINE
IPC: A23L29/269
Filed: 1998-05-12
Abstract: A UHT or sterilized lactic cream having a lactic fat content of between 10 and 30% and containing an additive chosen from: a)	starch at a content of between 1.5 and 4% b)	a starch/malto-dextrin mixture with a starch content of between 1.5 and 4% c)	xanthan/maltodextrin mixture containing a maltodextrin content of between 1.5 and 4% said cream having a viscosity of between 250 and 1600 mPas.  The whipping cream is composed essentially of a casein, egg or soybean protein, an emulsifier and an edible fiber and/or modified starch and has a lowered fat content relative to conventional whipped cream.
Patent NZ-332240-A (NZ)
Title: Substituted indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) and are therefor useful for treating inflammatory diseases
Inventor: MARFAT ANTHONY
IPC: C07D/
Filed: 1997-04-01
Abstract: Substituted indazole derivatives of the formula 1 and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF), where R is H, C1-6 alkyl, -(CH2)n(C3-7 cycloalkyl) where n is 0-2, (C1-6 alkoxy)C1-6 alkyl, C2-6 alkenyl, CH2n(C3-C9 heterocyclyl) where n is 0-2; R1 is H, C1-6 alkyl, C2-3 alkenyl, phenyl, C3-7 cycloalkyl or (C3-C7 cycloalkyl)C1-2alkyl where alkyl, phenyl and alkenyl R1 groups are optionally substituted by 1-3 substituents selected from methyl, ethyl, CF3 and halo; R2 is selected from 1a-1d where R3,  R4, R5, R6, R7 and R18 are defined in the specification.
Patent NZ-334454-A (NZ)
Title: substituted benzocycloheptapyridine derivatives and medicaments
Inventor: TAVERAS ARTHUR G
IPC: A61K31/5377
Filed: 1997-09-11
Abstract: The substituted benzocycloheptapyridine derivatives or pharmaceutically acceptable salts or solvates thereof have the formula I wherein: one of a, b, c or d is N or NR9 with R9 being O, CH3 or -(CH2)nCO2H and n is 1 to 3 and the remaining a, b, c or d are CR1 or CR2 or each of a, b, c, or d are independently CR1 or CR2; each of R1 and R2 are independently H, halo, CF3, COR10, SR10, S(O)tR11, SCN, N(R10)2, NR10R11, NO2, OC(O)R10, CO2R10, OCO2R11, CN, NHC(O)R10, NHSO2R10, CONHR10, CONHCH2CH2OH, NR10COOR11, SR11C(O)OR11, SR11N(R75)2, benzotriazol-1-yloxy, optionally substituted tetrazol-5-ylthio, alkynyl, alkenyl, alkyl or a group of formula II; R3 and R4 are independently H, or one of the substituents of R1 and R2 or together form an optionally substituted 5-7 membered carbocyclic ring fused to the benzene ring (ring III); R5, R6, R7 and R8 are independently H, CF3, COR10, or optionally substituted alkyl or aryl or R5 and R6 and/or R7 and R8 together form =O or =S; R10 is H, aralkyl, aryl or alkyl and R11 is alkyl or aryl; X is N, CH or C which C may contain an optional double bond (represented by the dotted line) to carbon atom 11; the dotted line between carbon atoms 5 and 6 is an optional double bond such that when the double bond is present, A and B are independently R10, halo, OR11, OCO2R11 or OC(O)R10 or when no double bond is present between carbon atoms 5 and 6 A and B are independently H2, (OR11)2, H and halo, dihalo, alkyl and H, (alkyl)2, H and OC(O)R10, H and OR10, =O, aryl and H, =NOR10 or -O-(CH2)p-O-; W is CN, COR12, -C(=NR13)-OR14, -C(=NR13)-NR10R16, -C(=CHNO2)-NHR10 or a  group of formula III and the rest of the variables are as defined in the specification. A pharmaceutical composition thereof useful in treating tumour cells or inhibiting farnesyl protein transferase.
Patent NZ-336000-A (NZ)
Title: Ocean wave energy extraction by means of a uni-directionally rotating turbine
Inventor: DENNISS TOM
IPC: F03B13/14
Filed: 1997-11-10
Abstract: A turbine operable to rotate uni-directionally when subjected to reversing axial fluid flows therethrough.  The turbine includes a rotor that comprises a central hub and a plurality of straight radially extending aerofoil sectioned blades each connected with the hub.  The cross section of each of the blades is symmetrical about a line defining the maximum camber height.  The shape of the blades and their orientation in relation to the hub facilitates uni-directional rotation of the rotor in response to reversing axial fluid flows therethrough.
Patent NZ-336441-A (NZ)
Title: Controlling the consistency of a beverage product, injection of ingredients into a mixing chamber dependent on gas pressure
Inventor: FRANK JIMMY I
IPC: A23L2/38
Filed: 1997-12-22
Abstract: In a beverage mixing system, liquid and gas are mixed in a mixing chamber.  A low point pressure value and a high point pressure value that are dependent on the pressure of the gas injected into the mixing chamber are set.  One or more ingredients are injected into the mixing chamber when the pressure in the mixing chamber is below the low set point value.  If the pressure is above the high set point value, the supply of one or more of the ingredients is reduced.  The pressure of the beverage in the mixing chamber is monitored, the set point pressures are adjusted if the pressure in the mixing chamber increases or decreases to a value that is outside of a predetermined range within a predetermined time.
Patent NZ-337257-A (NZ)
Title: Process and device for recovering and treating of aqueous solutions containing metal salts
Inventor: BILLINGTON PER
IPC: B01D1/12
Filed: 1998-03-05
Abstract: A method for treatment and processing of a solution of an organic fluid, water and one or more compounds of an alkaline earth metals, alkali metals and metal ions comprises: a) conducting a stream 5 consisting of organic fluid, water and one or more compounds of an alkaline earth metals, alkali metals and metal ions to a salt removing and crystallization unit (6) optionally over a diaphragm filtration unit (16); b) nucleating crystals of the compounds of the one or more compounds of an alkaline earth metals, alkali metals and/or metal ions by means of depressurization and temperature increase; c) evaporating and optionally partially condensing the stream (5) and providing thereby a stream (9,10) of water and organic fluid in vapour phase and a stream of (8 of figure 1, 20 and 23 in figure 3) of organic fluid in liquid phase and the compounds of one or more compounds of an alkaline earth metals, alkali metals and/or metal ions; d) conducting the stream of (8,20, 23) consisting of organic fluid and the compounds of one or more compounds of an alkaline earth metals, alkali metals and/or  metal ions to a salt reduction means (24) and e) removing the portion of the precipitated crystals and/or particles of the compounds of one or more compounds of an alkaline earth metals, alkali metals and/or metal ions.
Patent NZ-501658-A (NZ)
Title: Lantibiotic mutacin 1140 antimicrobial polypeptide and use thereof as a dentifrices
Inventor: HILLMAN JEFFREY D
IPC: C12R1/46
Filed: 1998-06-09
Abstract: Lantibiotic polypeptide compounds and compositions are useful as antimicrobials in antibiotic pharmaceutical preparations and as an antimicrobial or antiseptic dentifrice.
Patent NZ-506610-A (NZ)
Title: Gas treatment of molten metal, gas injected into melt using rotors in reaction chamber held under partial vacuum
Inventor: MYRBOSTAD ERLING
IPC: F27D27/00
Filed: 2000-08-29
Abstract: Molten metal is treated with gas and/or particulate material in a reactor 11.  The gas or particulate material is supplied through rotors 5.  Additional gas may be supplied through porous plug 8.  A partial vacuum is maintained in the space above the molten metal.  The vacuum assists in the degassing of the molten metal.  The rotors may depend from the top of the reactor, as shown, or may be placed in the sides or base of the reactor.
Patent NZ-507821-A (NZ)
Title: Indirectly determining temperature of blood in a container by measuring temperature of surrounding air and outside surface of container
Inventor: HVID NIELS
IPC: G01K11/00
Filed: 1997-01-08
Abstract: A method of indirectly determining the temperature of a blood sample in a container comprises: a) measuring the temperature of the outside surface of the container; b) measuring the temperature of the air surrounding the container and c) utilizing the formula Tblood  = ATair + BTsurface  to solve for the temperature of the blood wherein A is the heat transfer coefficient for the surrounding air; B is the heat transfer coefficient for the surface of the container.
Patent NZ-511229-A (NZ)
Title: Combined merchandise container and display device with a closure having a compartment within which there is a digital media disk
Inventor: LYONS JOHN
IPC: B65D51/20
Filed: 1999-01-22
Abstract: A closure (10) for a drink container (8) includes an inner member (12) having an opening (33) for receiving a straw and a peripheral portion for mounting to the container (8), and an outer member (14) fitted to the inner member to form a compartment therebetween. The outer member (14) has an opening (38) that is aligned with the opening of the inner member. The aligned openings permit penetration of a straw therethrough. The inner member (12) is shaped to prevent any beverage from within the container (8) from entering the compartment even while the straw penetrates the openings of the inner and outer members. The compartment holds a digital media disk (16).
Patent NZ-511382-A (NZ)
Title: A self countersinking screw fastener
Inventor: ROBERTS DAVID ALEXANDER
IPC: F16B35/06
Filed: 2001-04-27
Abstract: A screw fastener (10) including an elongated shank (11) having a longitudinal axis (A), a tip (12), a head (13) at the opposite end of the shank (11), and a self-tapping screw thread (14) extending along at least a major portion of the shank (11).  The head (13) includes a generally planer end face (17) which is generally perpendicular to the longitudinal axis (A), and which includes means (18) for cooperation with a screw driver.  The head (13) further includes boring means (15) that permits the head (13) to bore into a sheeting substrate. Control means are provided for controlling the depth of penetration of the head (13) into the sheeting substrate,
Patent NZ-512486-A (NZ)
Title: A solution having increased solubility for use in injectable drug products to treat acute pulmonary disorders
Inventor: TAKADA AKIRA
IPC: A61K47/02
Filed: 2001-06-19
Abstract: A solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glycine monosodium salt tetra-hydrate (I) comprising at least one pH adjuster selected from tri-sodium phosphate and a hydrate thereof, sodium hydroxide or potassium hydroxide and a drug product using the solution.  The solubility of the compound (I) increases upon use of the pH adjuster and thereby it is possible to provide a clear solution thereof and a drug product using it.  Using a mixture of water and an organic solvent greatly improves solubility and makes it possible to manufacture a solution of higher concentration of the compound (I), and high-dosage drug products using it. Compound (I) has an inhibitory activity against elastase and may be used in the treatment of acute pulmonary disorders
Patent NZ-519887-A (NZ)
Title: A fastener arrangement for an accessible file
Inventor: BLUMBERG MURRARY BASIL
IPC: B42F13/06
Filed: 2000-12-15
Abstract: This invention relates to a fastener assembly (10)  for an  accessible file. The fastener assembly (10)  includes  a fastener  base plate (12) having an upper face  (14)  and  a lower  face  (16),  with at least one prong  (20)  extending from the upper face (14). The assembly (10) also includes  a compressor  bar  (22) having at least one  hole  (24)  there through,   with   each  prong  (20)  extending   through   a corresponding hole (24) and capable of being retained  in  a fastened  position, and a securing means (18)  for  securing the  fastener base plate (12) to a file cover. The  securing means (18) is such that the fastener base plate (12) can  be secured  to  the  file  cover in an assembled  configuration together   with  the  compressor  bar  (22).  The  invention extends  to  a transfer mechanism component which,  together with   the   fastener  assembly  (10),  forms   a   fastener arrangement  for  an  accessible  file.  The  invention  yet further   extends  to  an  accessible  file  including   the transfer  arrangement,  to  a method  of  manufacturing  the accessible file, and to an apparatus therefor.